Entering text into the input field will update the search result below

Migraine Sufferers Find Relief In Thermal-Aid Headache Relief System

Apr. 24, 2014 11:38 AM ETPSHR
parlorfix profile picture
parlorfix's Blog
5 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

A study by the National Headache Foundation in Chicago said an estimated 30 million Americans suffered from migraine headaches in 2012. Of these figure, migraine headaches affected women almost three times more often than men, the study showed.

Medical experts explained that migraine headaches can vary from one person to another but they typically last from four hours up to 72 hours, with some experiencing the symptoms more frequently. Migraine sufferers report throbbing or pulsating pain on one side of the head, blurred vision, sensitivity to light and sound, nausea, and vomiting.

Thus, health and wellness consumers welcomed a new breakthrough product, the Thermal-Aid Headache Relief System, developed by Pacific Shore Holdings, Inc. Medical research showed the Thermal-Aid Headache Relief System with over a 90% efficacy in patients tested.

The Thermal-Aid Headache Relief System, which is touted to bring "relief in minutes," has captured the interest of the health and wellness industry. This claim is supported by medical research published in professional journals, such as Journal of Practical Pain Management, and was accepted for presentation at the 38th Annual Regional Anesthesiology and Acute Pain Medicine meeting and at the 16th Congress of the International Headache Society.

A breakthrough product, the Thermal-Aid Headache Relief System consists of an all natural topical cream which is absorbed transdermally. Developed by a physicians, it reduces the swelling of blood vessels and membranes thus providing relief from migraine and tension headaches.

The topical cream is applied directly to the forehead and temples, with an accompanying cooling mask to cover the eyes. Headache sufferers find relief in the system which has no harmful side effects.

The Thermal-Aid Headache product treats pain, muscle tension and light sensitivity in minutes. The Thermal-Aid line also provides relief to other ailments such as arthritis, back pain, muscle soreness, menstrual cramps, neck pain, carpal tunnel, sprains/strains, sunburn, fever, stomach aches flu symptoms, bug bites, lactation, babies with colic (under adult supervision), multiple sclerosis and growing pains.

Users welcome the fast and dependable relief provided by the treatment packs. In fact, it has become a favorite amongst physical therapists because the concept is simple and effective. In a four-month random study of osteoarthritis patients, this product was found to improve pain control of more than one-third of the patients and decreased their use of medications.

Other products in the line, include the Thermal-Aid Zoo, a kid-friendly animal stuffed with the patented Thermal-Aid Corn heating and Cooling element which is perfect for treating everything from bruises to earaches to growing pains.

Aside from this breakthrough product line, Pacific Shore provides consumer packaged goods and offers thermal-aid heating and cooling packs for adults, children, and pets. It also has natural pesticides and insecticides, SPF 30 lip balms, and natural aroma therapy shower sprays.

Pacific Shore Holdings, Inc. is a Los Angeles-based consumer packaged goods manufacturer. The company is committed to developing innovative, environmentally-friendly products that are safe, effective, and affordable. Their expert team of physicians, biochemists, and engineers takes green initiatives from concept to retail shelf, with several successful brands currently in market and under development.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You